Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706082 · ClinicalTrials.gov registry record
Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)
A clinical trial, sponsored by Actelion.
- Terminated
- Registry status
- 490
- Enrollment target
NCT00706082 is a clinical trial that was terminated before completion, run by Actelion. The registered enrollment target is 490 participants.
The verdict
NCT00706082 was terminated before completion, sponsored by Actelion.
- TERMINATED
- Registry status
- 490 participants
- Enrollment target
Study Summary
A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2008-10 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00706082
The ClinicalTrials.gov registry entry for NCT00706082 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 490 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actelion, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00706082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00706082 about?
NCT00706082 is a clinical study titled "Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)". A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension
What is the current status of trial NCT00706082?
This trial is currently terminated. The enrollment target is 490 participants. The study started on 2008-10. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00706082?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.